Australia's most trusted
source of pharma news
Friday, 31 October 2025
        
      
Posted 30 October 2025 PM
CSL Seqirus has launched in the Middle East, signing a deal with Saudi Arabia for access to advanced cell-based seasonal and pandemic influenza vaccines while boosting localised manufacturing in the country.
It's the Aussie giant's first expansion into the Middle East, and is part of a push to expand access to new markets that face a high flu burden by partnering with governments.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.